Analyst Ratings For Diffusion Pharmaceuticals (NASDAQ:DFFN)
Today, HC Wainwright initiated coverage on Diffusion Pharmaceuticals (NASDAQ:DFFN) with a Buy with a price target of $1.25.
Some recent analyst ratings include
- 3/21/2018-HC Wainwright initiated coverage with a Buy rating.
Recent Trading Activity for Diffusion Pharmaceuticals (NASDAQ:DFFN)
Shares of Diffusion Pharmaceuticals closed the previous trading session at with 0.0 shares trading hands.